Tech Company Financing Transactions
Akili Interactive Funding Round
Akili Interactive closed a $11.9 million Series B funding round on 7/20/2016. Backers included Amgen Ventures and Merck Capital Ventures.
Transaction Overview
Company Name
Announced On
7/20/2016
Transaction Type
Venture Equity
Amount
$11,900,000
Round
Series B
Investors
Merck Capital Ventures (Roel Bukthuis)
Proceeds Purpose
Akili will use the funds to support and expand clinical development of its clinical-stage products into new areas, with an expanded focus on neurodegeneration, and to build out its commercial infrastructure as Akili nears the market with its late-stage products.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
125 Broad St. 5th Floor
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Undisclosed
Website
Email Address
Overview
Transforming healthcare with clinically-validated digital medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Robert Perez
Chief Executive Officer
Eddie Martucci
Chief Financial Officer
Santosh Shanbhag
Chief Marketing Officer
Meghan Rivera
Chief Medical Officer
Anil Jina
VP - Engineering
Carl Gottlieb
VP - General Counsel
Jacqueline Studer
VP - Human Resources
Barrie Brian
VP - Marketing
Julie DiCarlo
Browse more venture capital transactions:
Prev: 7/20/2016: NurturMe venture capital transaction
Next: 7/20/2016: Guideline venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs